Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Non-Current Deferred Tax Liability (2024 - 2025)

Catheter Precision (VTAK) has disclosed Non-Current Deferred Tax Liability for 3 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability changed N/A to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a N/A change, with the full-year FY2024 number at $3.1 million, down 49.82% from a year prior.
  • Non-Current Deferred Tax Liability was $1.5 million for Q3 2025 at Catheter Precision, up from $1.5 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $6.3 million in Q4 2023 to a low of $1.5 million in Q2 2025.
  • A 3-year average of $3.0 million and a median of $2.4 million in 2025 define the central range for Non-Current Deferred Tax Liability.
  • Biggest YoY gain for Non-Current Deferred Tax Liability was 49.82% in 2024; the steepest drop was 49.82% in 2024.
  • Catheter Precision's Non-Current Deferred Tax Liability stood at $6.3 million in 2023, then tumbled by 49.82% to $3.1 million in 2024, then plummeted by 50.81% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Non-Current Deferred Tax Liability are $1.5 million (Q3 2025), $1.5 million (Q2 2025), and $2.4 million (Q1 2025).